InMode (InMode) Research & Development

: $13.4 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. InMode's Research & Development for the three months ended in Dec. 2023 was $3.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $13.4 Mil.

InMode Research & Development Historical Data

The historical data trend for InMode's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

5.70

9.47

9.53

12.43

13.41

InMode Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development																3.26	3.10	3.57	3.27	3.47

InMode Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.4 Mil.

InMode (NAS:INMD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

InMode Research & Development Related Terms

Thank you for viewing the detailed overview of InMode's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

InMode (InMode) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

154:Germany 154:Germany

Address

Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206

Website

https://www.inmodemd.com

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.